SCIENION Appoints Frauke Hein as CEO
Hein to lead as SCIENION plans for long-term profitable growth
Hein to lead as SCIENION plans for long-term profitable growth
EPO has been founded in 1997 as a spin-off from the Max-Delbrück-Center for Molecular Medicine [MDC] in Berlin Buch and is celebrating its 25th business anniversary this year. Since 1997 EPO has grown steadily and today has a loyal customer base of…
BERLIN, BOSTON, REYKJAVIK, 05 May 2022 – International digital therapeutics leader Sidekick Health (www.sidekickhealth.com) today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm N…
The start-up challenge connects top notch start-ups and manufacturing companies to increase manufacturing efficiency and sustainability together - at the Bits&Pretzels in Munich
MiGenTra and ProBioGen announce the appointment of Dr. Lutz Hilbrich, Chief Executive Officer of both companies, as Senator to the Senate of Economy Europe. The certificate of appointment was presented to Dr. Hilbrich in Strasbourg, France, today.
…Berlin, 12 May 2022. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) increased its sales by 13% to EUR 49.9 million in the first quarter of 2022. The net profit of EUR 6.7 million or EUR 0.32 per share was below the…
The German Innovation Award 2022 was presented in Munich on April 29. A very large number of research-intensive companies had applied for the prestigious award, which is conferred annually by the renowned weekly business magazine WirtschaftsWoche. …
The state of Berlin, Bayer, and Charité are planning a health care lighthouse project in the Mitte borough
Berlin, Germany; April 13, 2022: Together with numerous guests from politics, economics and science, SCIENION GmbH today celebrated the laying of the foundation stone of its new headquarters in Berlin Adlershof. The building complex will be…
Adrecizumab selected to receive funding from two COVID-19 drug development programs of the German Federal Ministry of Education and Research (BMBF)
By restoring vascular integrity, Adrecizumab addresses the endothelial barrier dysfunction as a…